SEK 0.04
(-1.61%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -61.33 Million SEK | -18.65% |
2022 | -51.68 Million SEK | -244.36% |
2021 | -15.01 Million SEK | -52.96% |
2020 | -9.81 Million SEK | 61.15% |
2019 | -25.25 Million SEK | 92.85% |
2018 | -353.3 Million SEK | -9746.96% |
2017 | -3.58 Million SEK | 50.54% |
2016 | -7.25 Million SEK | -555.28% |
2015 | -1.1 Million SEK | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 36.12 Million SEK | 376.49% |
2024 Q1 | -13.06 Million SEK | 78.7% |
2023 Q1 | 29.19 Million SEK | 156.49% |
2023 FY | -61.33 Million SEK | -18.65% |
2023 Q4 | -61.33 Million SEK | -88.02% |
2023 Q3 | -32.61 Million SEK | -138.28% |
2023 Q2 | 85.21 Million SEK | 191.87% |
2022 Q2 | -19.56 Million SEK | -27.51% |
2022 Q4 | -51.68 Million SEK | -79.13% |
2022 Q1 | -15.34 Million SEK | -2.24% |
2022 FY | -51.68 Million SEK | -244.36% |
2022 Q3 | -28.85 Million SEK | -47.47% |
2021 Q4 | -15.01 Million SEK | 30.06% |
2021 Q2 | -47.96 Million SEK | -291.66% |
2021 Q1 | -12.24 Million SEK | -24.8% |
2021 FY | -15.01 Million SEK | -52.96% |
2021 Q3 | -21.46 Million SEK | 55.26% |
2020 Q4 | -9.81 Million SEK | 43.55% |
2020 Q3 | -17.38 Million SEK | 53.62% |
2020 Q2 | -37.48 Million SEK | -35.09% |
2020 Q1 | -27.74 Million SEK | -9.85% |
2020 FY | -9.81 Million SEK | 61.15% |
2019 Q3 | -18.39 Million SEK | 0.31% |
2019 FY | -25.25 Million SEK | 92.85% |
2019 Q2 | -18.44 Million SEK | 5.69% |
2019 Q4 | -25.25 Million SEK | -37.35% |
2019 Q1 | -19.56 Million SEK | 94.46% |
2018 Q1 | 6.58 Million SEK | 283.61% |
2018 FY | -353.3 Million SEK | -9746.96% |
2018 Q4 | -353.3 Million SEK | -3074.67% |
2018 Q3 | -11.12 Million SEK | -2575.24% |
2018 Q2 | -416 Thousand SEK | -106.31% |
2017 Q1 | 7.25 Million SEK | 0.0% |
2017 FY | -3.58 Million SEK | 50.54% |
2017 Q4 | -3.58 Million SEK | 0.0% |
2016 FY | -7.25 Million SEK | -555.28% |
2015 FY | -1.1 Million SEK | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
AddLife AB (publ) | 5.01 Billion SEK | 101.222% |
Biotage AB (publ) | -444 Million SEK | 86.187% |
Bonesupport Holding AB (publ) | -149.86 Million SEK | 59.077% |
Doxa AB (publ) | -102.2 Million SEK | 39.99% |
Elekta AB (publ) | 4.46 Billion SEK | 101.372% |
iZafe Group AB (publ) | -2.65 Million SEK | -2206.506% |
Ortivus AB (publ) | 4.19 Million SEK | 1563.025% |
Ortivus AB (publ) | 4.19 Million SEK | 1563.025% |
S2Medical AB (publ) | -1.51 Million SEK | -3942.773% |
Synsam AB (publ) | 2.67 Billion SEK | 102.294% |